H Hasan New member 10 May 2022 #1 Bharat Biotech partners with CEPI to develop ‘variant-proof’ COVID-19 vaccine The international multidisciplinary consortium will constitute of Bharat Biotech, the University of Sydney and ExcellGene SA, Switzerland
Bharat Biotech partners with CEPI to develop ‘variant-proof’ COVID-19 vaccine The international multidisciplinary consortium will constitute of Bharat Biotech, the University of Sydney and ExcellGene SA, Switzerland
